Biotest AG (Biotest AG) Other Long Term Assets : $59.2 Mil (As of Mar. 2024)

View and export this data going back to 2014. Start your Free Trial

What is Biotest AG Other Long Term Assets?

Biotest AG's other long-term assets for the quarter that ended in Mar. 2024 was $59.2 Mil.

Biotest AG's quarterly other long-term assets increased from Sep. 2023 ($25.7 Mil) to Dec. 2023 ($66.5 Mil) but then stayed the same from Dec. 2023 ($66.5 Mil) to Mar. 2024 ($59.2 Mil).

Biotest AG's annual other long-term assets declined from Dec. 2021 ($23.5 Mil) to Dec. 2022 ($20.6 Mil) but then increased from Dec. 2022 ($20.6 Mil) to Dec. 2023 ($66.5 Mil).

Biotest AG Other Long Term Assets Historical Data

The historical data trend for Biotest AG's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biotest AG Other Long Term Assets Chart

Biotest AG Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Long Term Assets

Get a 7-Day Free Trial

26.56

15.57

23.50

20.55

66.52

Biotest AG Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Other Long Term Assets	Get a 7-Day Free Trial															24.09	24.05	25.72	66.52	59.24

Biotest AG Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

Biotest AG (Biotest AG) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biotest AG (OTCPK:BIESF) » Definitions » Other Long Term Assets

Comparable Companies

Traded in Other Exchanges

BIO3:Germany BIO3:Austria

Address

Landsteinerstrasse 5, Dreieich, DEU, 63303

Website

https://www.biotest.com

Biotest AG is a supplier of biological medicines. The company produces its products from human blood plasma or manufactured by using biotechnology methods. It is engaged in the area of hematology, clinical immunology, and intensive care medicine. The operating business segments are Therapy, Plasma and Services, and Other segments. It generates maximum revenue from the Therapy segment. Geographically, it derives a majority of revenue from Central Europe and also has a presence in other countries.